Abstract
LBA103 ICRA: Efficacy of paclitaxel with tremelimumab +/- durvalumab in metastatic urothelial carcinoma after progression on platinum chemotherapy and anti-PD-(L)1
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have